Phenotypical and treatment response heterogeneity in a cohort of normal pressure hydrocephalus patients
Objective: To clinically characterize a cohort of patients with normal pressure hydrocephalus (NPH) to identify possible clinical and humoral biomarkers that can predict the response…Longitudinal evaluation of hypomimia in individuals with Parkinson’s disease using a video analytics tool
Objective: To assess hypomimia longitudinally in individuals with Parkinson’s disease (PD) using a video analytics tool. Background: Recent advancements in video analytics - the use…“Mirror” jaw movements in parkinsonian patients
Objective: To describe synchronous involuntary rhythmic jaw movements during voluntary hand movements in parkinsonian patients. We called them "mirror" jaw movements. Background: Mirror movements (MM)…Clinicopathologic features of primary lateral sclerosis with TDP-43 presenting as atypical parkinsonism
Objective: To clarify clinicopathologic features of pathologically-confirmed primary lateral sclerosis (PLS). Background: PLS is a neurodegenerative disorder characterized by slowly progressive upper motor neuron signs…Case report: Parkinsonim with dyskinesia secondary to amyloid angiopathy
Objective: To report a case of parkinsonism secondary to amyloid angiopathy and discuss the pathophysiology and treatment of this entity. Background: Cerebral amyloid angiopathy is…Burden of COVID-19 among patients with Parkinson’s disease and associated clinical outcomes: Evidence from a meta-analysis
Objective: To understand the burden of covid-19 among patients with Parkinson’s disease and associated clinical outcomes. Background: COVID-19 has affected millions of patients around the…Capturing the complexity of patients with parkinsonism: Baseline characteristics of participants in the PRIME-UK cross-sectional study
Objective: This cross-sectional study seeks to describe the symptomatology and health needs of a representative sample of people with parkinsonism, including those living with frailty,…CSF biomarkers in neurodegenerative parkinsonism can distinguish between multiple system atrophy and 4-repeat tauopathies, but not between disease with Lewy bodies and multiple system atrophy
Objective: To assess the usefulness of a defined set of blood-based and cerebrospinal fluid-based biomarkers in the differential diagnosis of neurodegenerative proteinopathies. Background: The diagnostic…Clinical presentation of SNCA Duplication Parkinsonism in a Family Kindred
Objective: To report phenotype variability in a family with SNCA duplication associated Parkinsonism. Background: Pathogenic variants in SNCA, the gene coding for α-synuclein, cause familial…Characteristics and Techniques to Improve Micrographia in Parkinson’s Disease
Objective: To analyze and identify the characteristics found in micrographia and provide methods of improving the symptom. Background: Micrographia, also known as small handwriting, is…
- « Previous Page
- 1
- …
- 33
- 34
- 35
- 36
- 37
- …
- 388
- Next Page »